Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Mutual Funds
Invest in Mutual Funds
Invest in direct mutual funds at zero charges via lump sump investments or SIPs
SHILPAMED •NSE
Shilpa Medicare
₹604.250.65 (0.11%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events
Performance
Today’s low
597.50
Today’s high
610.80
52 week low
259.50
52 week high
650.00
Open price
601.00
Previous close
603.60
Live volume
2,39,251
Lower circuit
482.90
Upper circuit
724.30
Fundamentals
Market Cap
₹11,797Cr
ROE
9.39%
P/E Ratio(TTM)
48.48
EPS(TTM)
12.44
P/B Ratio
4.55
Dividend Yield
0.10%
Industry P/E
36.98
Book Value
132.49
Debt to Equity
0.25
Face Value
1
Financial performance
MAR '26
Revenue (Cr)
₹439
+6.85%
Profit (Cr)
₹108
+141.79%
0150300450600
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
| Revenue growth | Value |
|---|---|
| 1Y (TTM) | +30% |
| 3Y CAGR | +4% |
| Profit growth | Value |
|---|---|
| 1Y (TTM) | +643% |
| 3Y CAGR | +9% |
About
Starting its journey in 1987, Shilpa Medicare Limited has grown into a well-regarded manufacturer of Active Pharmaceutical Ingredients (APIs) and other medical formulations. The company firmly believes that every person in the world deserves the right to have access to high-quality and affordable healthcare services and products. A core principle that guides all its business activities is the commitment to maintaining the highest possible ethical standards in everything the company does. It serves customers worldwide by providing a broad selection of products, including oncology and non-oncology APIs, specialized formulations, and advanced biosimilars. Through consistent investment in research and development, the organization works towards creating and supplying innovative new solutions to meet various healthcare needs. The company has established a strong leadership position in the cancer-drug segment, securing almost 30% of the worldwide market for top oncology medicines.;
CEO/MD
Mr. Vishnukant Chaturbhuj Bhutada
Founded in
1987
NSE symbol
SHILPAMED
Shareholding Pattern
Jun '26
Mar '26
Dec '25
Sep '25
Jun '25
Mutual Funds Invested (4)
Similar stocks
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,586.80 -65.60 (1.41%) | 21,275.44 | 29.45 | 5.06 | ||
Granules IndiaGRANULES | ₹845.00 -7.55 (0.89%) | 21,108.58 | 31.87 | 4.47 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,938.50 +66.50 (0.84%) | 19,684.00 | 104.97 | 22.55 | ||
₹1,387.80 -7.80 (0.56%) | 19,333.78 | 29.86 | 4.95 |
Livesquawk •
Shilpa Medicare partners with Orion to supply EU-GMP nivolumab biosimilar.
The deal targets Europe's $4.1B PD-1 immunotherapy market post-exclusivity.
2026
22
May
Quarterly & Annual Result
Release date
6
Feb
Quarterly Result
Release date
2025
13
Nov
Quarterly Result
Release date
3OctBonusEx date1:1Ratio
3
Oct
Bonus
Ex date
1:1
Ratio
For every 1 shares you hold, you will receive 1 additional shares
Bonus ratio1:1
Ex date3 Oct ‘25
Record date3 Oct ‘25
Announcement date18 Sep ‘25
18SepBonusAnnounced1:1Ratio
18
Sep
Bonus
Announced
1:1
Ratio
For every 1 shares you hold, you will receive 1 additional shares
Bonus ratio1:1
Ex date3 Oct ‘25
Record date3 Oct ‘25
Announcement date18 Sep ‘25
17SepDividendEx date₹1.00per share
17
Sep
Dividend
Ex date
₹1.00
per share
For each share you hold, you will receive ₹1.00
Dividend amount₹1.00 per share
Dividend TypeFinal
Ex Date17 Sep ‘25
Record Date17 Sep ‘25
Announcement date26 May ‘25
13
Aug
Quarterly Result
Release date
26MayDividendAnnounced₹1.00per share
26
May
Dividend
Announced
₹1.00
per share
For each share you hold, you will receive ₹1.00
Dividend amount₹1.00 per share
Dividend TypeFinal
Ex Date17 Sep ‘25
Record Date17 Sep ‘25
Announcement date26 May ‘25
Events calendar
View upcoming events in other stocks